These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35924772)

  • 1. Biosafety of personnel of microbiological laboratories in the context of the Federal Law of the Russian Federation № 492-FZ of December 30, 2020 «On the biological safety of the Russian Federation».
    Matosova EV; Andryukov BG; Bynina MP; Drobot EI; Lyapun IN
    Klin Lab Diagn; 2022 Jul; 67(7):414-422. PubMed ID: 35924772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks.
    Peng H; Bilal M; Iqbal HMN
    Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30501091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hidden face of academic researches on classified highly pathogenic microorganisms.
    Devaux CA
    Infect Genet Evol; 2015 Jan; 29():26-34. PubMed ID: 25445654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current biosafety in clinical laboratories in Japan: report of questionnaires' data obtained from clinical laboratory personnel in Japan].
    Goto M; Yamashita T; Misawa S; Komori T; Okuzumi K; Takahashi T
    Kansenshogaku Zasshi; 2007 Jan; 81(1):39-44. PubMed ID: 17338315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biosafety and biosecurity in the medical laboratory. Update and trends].
    Ionescu G; Neguţ M; Combiescu AA
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):91-9. PubMed ID: 19326721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.
    Kimman TG; Smit E; Klein MR
    Clin Microbiol Rev; 2008 Jul; 21(3):403-25. PubMed ID: 18625678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.
    Lippi G; Adeli K; Ferrari M; Horvath AR; Koch D; Sethi S; Wang CB
    Clin Chem Lab Med; 2020 Jun; 58(7):1053-1062. PubMed ID: 32396137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral infections in workers in hospital and research laboratory settings: a comparative review of infection modes and respective biosafety aspects.
    Pedrosa PB; Cardoso TA
    Int J Infect Dis; 2011 Jun; 15(6):e366-76. PubMed ID: 21497126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biosafety in laboratories concerning exposure to biological agents].
    Vonesch N; Tomao P; Di Renzi S; Vita S; Signorini S
    G Ital Med Lav Ergon; 2006; 28(4):444-56. PubMed ID: 17380946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of laboratory biosafety and protective measures in blood transfusion departments during the COVID-19 pandemic.
    Liu H; Liu L; Zhang J; Shang X; Chen S; Li X; Gui R; Huang R
    Vox Sang; 2021 Jul; 116(6):682-691. PubMed ID: 33529377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active surveillance of health and safety in microbiology laboratories.
    Workman MR; Wall PG; Tearle P; O'Mahony M; Brunton WA
    Commun Dis Rep CDR Rev; 1995 Mar; 5(4):R54-6. PubMed ID: 7735351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosafety and Biohazards: Understanding Biosafety Levels and Meeting Safety Requirements of a Biobank.
    Ta L; Gosa L; Nathanson DA
    Methods Mol Biol; 2019; 1897():213-225. PubMed ID: 30539447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.
    Wang K; Zhu X; Xu J
    Health Secur; 2020; 18(3):232-236. PubMed ID: 32522074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosafety protection and workflow of clinical microbiology laboratory under COVID-19: A review.
    Zhou W; Zou L; Zhu F; Yang J
    Medicine (Baltimore); 2022 Nov; 101(45):e31740. PubMed ID: 36397385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing biosafety level and LAI among the staff of medical laboratories.
    Kozajda A; Bródka K; Szadkowska-Stańczyk I
    Med Pr; 2013; 64(4):473-86. PubMed ID: 24502112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosafety breaches. Accidents spur a closer look at risks at biodefense labs.
    Kaiser J
    Science; 2007 Sep; 317(5846):1852-4. PubMed ID: 17901309
    [No Abstract]   [Full Text] [Related]  

  • 18. General biosafety measures for laboratory environments, outpatient clinics, medical centers, and veterinary hospitals during the SARS-CoV-2 pandemic.
    Ulsenheimer BC; Pereira DIB; Dos Santos HF; von Laer AE; Tonin AA; da Costa MM; Sangioni LA; de Avila Botton S
    Braz J Microbiol; 2022 Sep; 53(3):1715-1721. PubMed ID: 35352318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring.
    Orelle A; Nikiema A; Zakaryan A; Albetkova AA; Keita MS; Rayfield MA; Peruski LF; Pierson A
    Health Secur; 2022; 20(6):488-496. PubMed ID: 36383124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The characteristics of repeated medical social expertise of adult population of the Russian Federation in 2018-2020].
    Horkova OV; Puzin SN; Bogova OT
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Nov; 29(6):1542-1546. PubMed ID: 34882330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.